 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 2002, 22(12):4897-4905
Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous
Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic
Transgenic Mice
Gwenn A.
Garden1,
Randell T.
Libby2,
Ying-Hui
Fu7,
Yoshito
Kinoshita3,
Jing
Huang4,
Daniel E.
Possin4,
Annette C.
Smith2,
Refugio A.
Martinez2,
Gabriel C.
Fine1,
Sara K.
Grote1, 2,
Carol B.
Ware5,
David D.
Einum8,
Richard S.
Morrison3,
Louis J.
Ptacek8, 9,
Bryce L.
Sopher2, and
Albert R. La
Spada1, 2, 6
Departments of 1 Neurology, 2 Laboratory
Medicine, 3 Neurological Surgery,
4 Ophthalmology, 5 Comparative Medicine, and
6 Medicine (Division of Medical Genetics), University of
Washington Medical Center, Seattle, Washington 98195-7110, Departments
of 7 Neurobiology and Anatomy and 8 Human
Genetics, and 9 Howard Hughes Medical Institute,
University of Utah, Salt Lake City, Utah 84112
Spinocerebellar ataxia (SCA) type 7 is an inherited
neurodegenerative disorder caused by expansion of a polyglutamine tract within the ataxin-7 protein. To determine the molecular basis of
polyglutamine neurotoxicity in this and other related disorders, we
produced SCA7 transgenic mice that express ataxin-7 with 24 or 92 glutamines in all neurons of the CNS, except for Purkinje cells.
Transgenic mice expressing ataxin-7 with 92 glutamines (92Q) developed
a dramatic neurological phenotype presenting as a gait ataxia and
culminating in premature death. Despite the absence of expression of
polyglutamine-expanded ataxin-7 in Purkinje cells, we documented severe
Purkinje cell degeneration in 92Q SCA7 transgenic mice. We also
detected an N-terminal truncation fragment of ataxin-7 in
transgenic mice and in SCA7 patient material with both anti-ataxin-7
and anti-polyglutamine specific antibodies. The appearance of truncated
ataxin-7 in nuclear aggregates correlates with the onset of a disease
phenotype in the SCA7 mice, suggesting that nuclear localization and
proteolytic cleavage may be important features of SCA7 pathogenesis.
The non-cell-autonomous nature of the Purkinje cell degeneration in our
SCA7 mouse model indicates that polyglutamine-induced dysfunction in
adjacent or connecting cell types contributes to the neurodegeneration.
Key words:
polyglutamine; ataxin-7; neurodegeneration; Purkinje
cell; non-cell autonomous; truncation; proteolytic cleavage
Copyright © 2002 Society for Neuroscience 0270-6474/02/22124897-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. C. Warby, C. N. Doty, R. K. Graham, J. B. Carroll, Y.-Z. Yang, R. R. Singaraja, C. M. Overall, and M. R. Hayden
Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus
Hum. Mol. Genet.,
August 1, 2008;
17(15):
2390 - 2404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Gatchel, K. Watase, C. Thaller, J. P. Carson, P. Jafar-Nejad, C. Shaw, T. Zu, H. T. Orr, and H. Y. Zoghbi
The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7
PNAS,
January 29, 2008;
105(4):
1291 - 1296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Young, L. Gouw, S. Propp, B. L. Sopher, J. Taylor, A. Lin, E. Hermel, A. Logvinova, S. F. Chen, S. Chen, et al.
Proteolytic Cleavage of Ataxin-7 by Caspase-7 Modulates Cellular Toxicity and Transcriptional Dysregulation
J. Biol. Chem.,
October 12, 2007;
282(41):
30150 - 30160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir, A. Mouatt-Prigent, M.-P. Muriel, L. Morel, M. Ruberg, A. Brice, et al.
A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes
J. Neurosci.,
March 7, 2007;
27(10):
2483 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Thomas Jr, G. S. Fraley, V. Damien, L. B. Woodke, F. Zapata, B. L. Sopher, S. R. Plymate, and A. R. La Spada
Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy
Hum. Mol. Genet.,
July 15, 2006;
15(14):
2225 - 2238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Taylor, S. K. Grote, J. Xia, M. Vandelft, J. Graczyk, L. M. Ellerby, A. R. La Spada, and R. Truant
Ataxin-7 Can Export from the Nucleus via a Conserved Exportin-dependent Signal
J. Biol. Chem.,
February 3, 2006;
281(5):
2730 - 2739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Adachi, M. Katsuno, M. Minamiyama, M. Waza, C. Sang, Y. Nakagomi, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, et al.
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
Brain,
March 1, 2005;
128(3):
659 - 670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys
Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice
J. Biol. Chem.,
December 31, 2004;
279(53):
55969 - 55977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Goti, S. M. Katzen, J. Mez, N. Kurtis, J. Kiluk, L. Ben-Haiem, N. A. Jenkins, N. G. Copeland, A. Kakizuka, A. H. Sharp, et al.
A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration
J. Neurosci.,
November 10, 2004;
24(45):
10266 - 10279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Helmlinger, G. Abou-Sleymane, G. Yvert, S. Rousseau, C. Weber, Y. Trottier, J.-L. Mandel, and D. Devys
Disease Progression Despite Early Loss of Polyglutamine Protein Expression in SCA7 Mouse Model
J. Neurosci.,
February 25, 2004;
24(8):
1881 - 1887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, G.-H. Peng, X. Wang, A. C. Smith, S. K. Grote, B. L. Sopher, and A. R. La Spada
Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization
Hum. Mol. Genet.,
January 1, 2004;
13(1):
53 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michalik and C. Van Broeckhoven
Pathogenesis of polyglutamine disorders: aggregation revisited
Hum. Mol. Genet.,
October 15, 2003;
12(90002):
R173 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Huynh, H.-T. Yang, H. Vakharia, D. Nguyen, and S. M. Pulst
Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death
Hum. Mol. Genet.,
July 1, 2003;
12(13):
1485 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Libby, D. G. Monckton, Y.-H. Fu, R. A. Martinez, J. P. McAbney, R. Lau, D. D. Einum, K. Nichol, C. B. Ware, L. J. Ptacek, et al.
Genomic context drives SCA7 CAG repeat instability, while expressed SCA7 cDNAs are intergenerationally and somatically stable in transgenic mice
Hum. Mol. Genet.,
January 1, 2003;
12(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fossale, V. C. Wheeler, V. Vrbanac, L.-A. Lebel, A. Teed, J. S. Mysore, J. F. Gusella, M. E. MacDonald, and F. Persichetti
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice
Hum. Mol. Genet.,
September 15, 2002;
11(19):
2233 - 2241.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|